Full Course Description
Advancing Thyroid Health: Pharmacotherapy Approaches in Women’s Health
In this engaging session, Dr. Melody Hartzler will delve into the critical aspects of pharmacotherapy for thyroid disorders, with a special focus on women’s health. You will gain a comprehensive understanding of the various thyroid conditions prevalent among women and the latest pharmacological treatments available. Through detailed discussions on drug mechanisms, management strategies, and integrative approaches, this presentation aims to equip healthcare providers with the knowledge and tools necessary to optimize thyroid health in patients. This session is ideal for those looking to enhance their expertise in women’s health pharmacology.
Program Information
Objectives
- Analyze the epidemiology and clinical presentation of common thyroid disorders in women.
- Evaluate the various pharmacological treatments available for managing thyroid disorders.
- Identify monitoring strategies and patient education techniques to enhance treatment efficacy and compliance.
- Incorporate integrative approaches for thyroid nutrient supplementation.
Outline
Thyroid Disorders: Prevalence and Impact on Women’s Health
- Types of disorders: Hypothyroidism, hyperthyroidism, thyroid nodules
Pharmacological Treatment Options
- Levothyroxine for hypothyroidism: Dosage and considerations
- Antithyroid medications for hyperthyroidism: Methimazole and propylthiouracil
Clinical Management Strategies
- Best practices to monitor thyroid function
- Patient education and compliance: Techniques for effective communication
Integrative Approaches
- Nutrient deficiencies related to hypothyroidism
- Diet and lifestyle in management of thyroid disorders
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/24/2024
Anti-Obesity Medication Treatments: Clinical Pearls for Prescribers
Anti-Obesity Medication Treatments: Clinical Pearls for Prescribers explores the pathophysiology of obesity, current FDA-approved anti-obesity medications, and their mechanisms of action to equip providers with the knowledge to select and manage patients with obesity confidently. Ahunna Freeman, PharmD, BCGP, will highlight valuable clinical pearls and include interactive patient cases to optimize patient outcomes in the management of obesity.
Program Information
Objectives
- Evaluate the epidemiology and pathophysiology of obesity.
- Determine clinical practice guidelines in the management of obesity in adults.
- Analyze FDA-approved pharmacologic options for the management of obesity.
- Develop appropriate therapeutic approaches for patient cases.
Outline
Epidemiology/Pathophysiology of Obesity
- Obesity as a chronic, multifactorial condition with health consequences
- Factors that affect or contribute to obesity
- Limitations of lifestyle interventions in the management of obesity
Mechanism of Action for Anti-Obesity Medications (AOMs)
- Explain the physiology of weight regulation
- Patient: Caloric deficit, physical activity, stress management/psychologically
- Metabolic adaptation: Hormones & metabolism
- Treatment guidelines: Non-pharmacological and pharmacological options
- Role of AOMs in weight management
Key Medications in the Management of Obesity
- Clinical pearls of each FDA-approved AOM:
- Initiating dose and formulations
- Therapeutic strength
- FDA-approved criteria
- Potential adverse effects
- Monitoring plans
- Use in special populations/individualized treatment based on comorbidities
- Use with other medications/potential interactions
- Approximate Cost
Study trial results for the newest class of AOMs for clinical significance
Highlights from current research on AOMs Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/24/2024
Menopause and Musculoskeletal Health: Exploring the Intersection of Lifestyle and Pharmacotherapy
The growing aging population poses challenges in addressing numerous health concerns, including musculoskeletal health. Menopause is a natural event in a women’s life but along with the physical effects of aging and weight concerns at this stage of life, the impact on muscle and bone health is often overlooked when considering long-term patient outcomes.
As the prevalence of sarcopenia and osteoporosis increases, women are seeking help from clinicians to make informed decisions about their health. Still, they are bombarded by conflicting messages about lifestyle and pharmacotherapy options for prevention and treatment. Val Schonberg is a registered dietitian and certified menopause practitioner specializing in musculoskeletal health who will explore topics related to evidence-based nutrition, physical activity, supplements, hormone therapy, and individualized treatment strategies for muscle and bone injuries and osteoporosis.
Program Information
Objectives
- Differentiate the impact of aging from shifting hormones on long-term health concerns.
- Identify how a progressive decline in musculoskeletal health is a major healthcare concern.
- Apply appropriate therapeutic interventions to address musculoskeletal health concerns that are within your practice scope.
- Summarize best practices to work with a multidisciplinary group of health professionals to promote positive health outcomes for patients.
Outline
Menopause and Aging
- Body composition and weight changes in midlife
- The impact of disordered eating, eating disorders, and weight loss on MSK health
- Use of menopause hormone therapy
Osteosacropenia
- Pathophysiology and screening
- Athletes and active women
- Recognizing low energy availability in MSK patients
- Differentiating secondary amenorrhea from perimenopause
Muscle Health
- Age-related anabolic resistance
- Impact on health (impaired glucose tolerance/diabetes, CVD, and mobility)
- Sarcopenia (loss of lean tissue) – risk factors and pathophysiology
Bone Health
- Age-related changes in bone density
- Understanding low bone density (osteopenia) vs osteoporosis
- Risk factors: identifying modifiable vs non-modifiable
- Diagnosis – current practice recommendations
Treatment to Optimize Musculoskeletal Health
- Nutritional – guidelines for protein, vitamin D, calcium, and supplements
- Physical activity
- Pharmacotherapy
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/24/2024
Medication Management of Migraines in Women: Individualized Treatment Plans Including Abortive Use Medications and Migraine Prophylaxis
Deepen your understanding and knowledge in the treatment of migraines in women. Kelly Sklanka, PharmD, will focus on recognizing the impact migraines have on women and their quality of life, the identification of triggers and current literature to guide pharmacologic treatment strategies for patient relief. Particular areas of focus will include the pharmacology of available medications for abortive use and migraine prophylaxis, along with specific pearls and recommendations to guide development of an individualized treatment plan. Through case studies and evidence-based reviews, you will gain the tools and confidence needed to help women achieve more migraine free days.
Program Information
Objectives
- Evaluate the pathophysiology, common triggers and burden of migraines on women.
- Analyze current pharmacology of available treatment options for abortive therapy and migraine prophylaxis.
- Incorporate current guidelines and literature to support decision making processes in medication selection.
- Design a treatment plan for various patient encounters related to migraine management.
Outline
Girls Just Want to Have … Migraines?
- Migraine pathophysiology and associated triggers
- Current pharmacologic and nonpharmacologic treatment options
- Impact of migraines on quality of life in women
Abort Mission!
- Best prescriptive practices for abortive medications
- Selection processes to determine appropriate abortive therapy
Prevention is the Best Medicine
- Options for migraine prophylaxis and the pharmacology of events
- Shared decision making to select an appropriate medication for migraine prophylaxis
Can’t Get You Out of my Head – or Can I?
- Create treatment plans for individual patient cases
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/24/2024
Hormone Replacement Therapy Risks & Benefits: Current Guidelines and Recommendations for Female Patients
Hormone Replacement Therapy (HRT) has long been a topic of interest and debate in the management of menopausal symptoms, particularly vasomotor symptoms such as hot flashes and night sweats. Deidre Arms, MSN, APRN, CNP will provide a comprehensive overview of HRT, focusing on the effectiveness in alleviating vasomotor symptoms and improving the quality of life for menopausal women. You will gain insights into the physiological mechanisms underlying vasomotor symptoms and how HRT mitigates these effects.
Explore the various forms of HRT available, their respective advantages and drawbacks, and the importance of personalized treatment plans. The session will also address the potential risks associated with HRT, and how to balance these risks against the benefits. Current guidelines and recommendations from leading health organizations will be reviewed to aid in clinical decision-making. The discussion will also include alternative and complementary therapies for patients who cannot or choose not to use HRT.
Program Information
Objectives
- Evaluate vasomotor symptoms and their prevalence in menopausal women.
- Explain the mechanism of action of hormone replacement therapy (HRT) in managing vasomotor symptoms.
- Analyze the benefits and risks associated with HRT.
- Plan to incorporate current guidelines and recommendations for the use of HRT in menopausal women.
Outline
Hormone Replacement Therapy (HRT)
- Types of HRT (estrogen-only, combined estrogen-progestogen)
- Mechanism of action in alleviating vasomotor symptoms
- Forms of HRT (oral, transdermal, topical, vaginal)
Benefits of HRT
- Relieve of vasomotor symptoms
- Additional benefits (bone health, potential cardiovascular benefits)
Risks and Considerations
- Potential risks (cancer, cardiovascular risks, side effects)
- Balancing risks and benefits
- Contraindications and alternative treatments
Guidelines and Recommendations
- Current guidelines from major health organizations
- Criteria for patient selection
- Monitoring and follow-up
alternative and Complementary Therapies
- Non-hormonal treatments (SSRIs, SNRIs, gabapentin, clonidine)
- Lifestyle modifications (diet, exercise, stress management)
- Complementary therapies (herbal supplements, acupuncture, mindfulness)
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/24/2024
Premenstrual Dysphoric Disorder and Premenstrual Syndrome: Improve Patient Suffering with Medication Management Updates
Tara Harding, DNP, FNP-C will provide you with a comprehensive current look at Premenstrual Dysphoric Disorder (PMDD) and Premenstraual Syndrome (PMS). Explore the diagnostic challenges, including overlapping symptoms and limited provider awareness, to shed light on why these conditions are often misdiagnosed or overlooked.
The session will delve into a detailed exploration of traditional pharmacological treatment options, emphasizing their benefits, risks, and considerations. Dr. Harding will address prescriptive challenges and provide updates on medication management to ensure you are equipped with the latest knowledge for delivery of up-to-date patient care.
Key aspects of lifestyle modifications and unconventional care approaches will be delivered as well, to provide an integrative management plan for patients with PMDD/PMS. Case studies will be reviewed to further illustrate successful management of PMDD/PMS, highlighting key take aways and best practices from real patient scenarios.
You will leave with practical tools and resources to enhance patient-centered care and new strategies to improve communication, even as patients may initially feel uncomfortable. Advance your skills to better support women suffering from PMDD and PMS, ultimately improving patient outcomes.
Program Information
Objectives
- Plan for diagnostic challenges for female patients presenting with Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Syndrome (PMS) symptoms.
- Evaluate the latest updates in medication management options to treat PMDD/PMS.
- Explore case reviews for examples of successful management of PMDD/PMS.
- Explain new strategies that allow patients to more fully share their PMDD/PMS concerns
Outline
Premenstrual Dysphoric Disorder (PMDD) and Premenstraual Syndrome (PMS): Symptoms and the Diagnostic Challenges
- Differentiating PMDD and PMS
- Symptoms and prevalence among women
- Overlapping symptoms and limited provider awareness
Compare and Contrast Pharmacological Treatment Options for PMDD/PMS
- Updates in medication management: Mechanisms of action, benefits, risks, and side effects
- Prescriptive challenges for PMDD/PMS
Case Studies to Illustrate Successful Management of PMDD/PMS
- Case reviews to highlight key takeaways
- Lessons learned and best practices
Practical Tools and Resources for Healthcare Providers
- Tools and resources to aid in patient-centered diagnosis and treatment
- Strategies to communicate PMDD/PMS concerns between patients and healthcare providers
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/25/2024
New Solutions for Vasomotor Symptoms in Menopause
Every woman will transition into menopause, with the typical timeframe being from 45 to 55 years of age. The years preceding menopause are labeled the perimenopause phase of life. A very high percentage of women will experience both overt and covert symptoms during these years, with vasomotor symptoms comprising the most common and most discussed of the overt type. Felice Gersh, MD, a multi-award-winning physician with dual board certifications in OB-GYN and integrative medicine, will deliver a powerful presentation, focusing on the etiology and treatment of vasomotor symptoms, including hormone therapy. You will walk away with new solutions to address your patients’ concerns surrounding VSM.
Program Information
Objectives
- Explain the key issues facing women throughout the years of perimenopause and menopause.
- Determine the female changes that present as estrogen production changes.
- Evaluate the various manifestations and medical significance of vasomotor symptoms.
- Develop a medical and integrative approach to treating and resolving vasomotor symptoms.
- Formulate a hormone use approach for the treatment of vasomotor symptoms.
Outline
- What is menopause and why does it matter
- What is estrogen and what role does it play in maintaining female wellbeing
- During menopause, what happens to the various organ systems of the body
- What effect does menopause have on the central nervous system
- Explain the effect menopause has on the autonomic nervous system
- What clinical significance, if any, do vasomotor symptoms have
- Should vasomotor symptoms be treated
- What role should hormone therapy play in the treatment of vasomotor symptoms – pros and cons
- What are the various non-hormonal options available to address vasomotor symptoms, including pros and cons
Copyright :
10/08/2024
Realize the Potential of Rapid-Acting Treatments for Depression
Optimal management of depression begins with adequate screening and early introduction of appropriate therapy. Monoaminergic antidepressants, which are currently considered the standard of care, have several limitations, including low therapeutic response rates, suboptimal efficacy and remission rates, and adverse effects that may impact patient adherence. Josh Hamilton, DNP, APRN-BC, CTMH, CNE, CLNC, FAANP will explore novel pathways involved in the etiology of depression, including glutamatergic and GABAergic modulation. Discover when newer pharmacologic agents, including neuroactive steroids and glutamatergic antidepressants are appropriate. Take away practical prescriptive considerations and apply them to real-world cases.
Program Information
Objectives
- Advance your understanding of the mechanisms of action for novel rapid-acting pharmacotherapies for depression.
- Evaluate the efficacy and unique safety profiles associated with novel antidepressants.
- Select appropriate patients for treatment with rapid-acting antidepressants.
- Explain the skills needed to engage in shared decision making to optimize patient outcomes.
Outline
Novel Rapid-Acting Pharmacotherapies for Depression: Mechanisms of Action
- Treatment-as-usual
- Unmet needs
- MDA receptor antagonists
- Neuroactive steroid GABA-A modulators
Efficacy and Unique Safety Profiles Associated with Novel Antidepressants
- Neurobiology of depression, revisited (GABA/glutamate)
- Clinical studies and outcomes
Select Appropriate Patients for Treatment with Rapid-Acting Antidepressants
- Case applications
- TRD/anhedonia
- PPD
- Suicidality
Shared Decision Making to Optimize Patient Outcomes
- Shared decision-making with patients
- Case applications, continued
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/25/2024
Tailoring Cardiovascular Care for Women
The course objective is to review the current state of women’s cardiovascular (CV) health and how traditional and non-traditional CV risk factors impact women’s CV risk across the life span. The course will also help to gain a better understanding of the presentations and mechanisms of ischemia in women and examine how we can tailor cardiovascular practice to incorporate sex-specific considerations to enhance women’s CV health and well-being.
Program Information
Objectives
- Review the current state of women’s cardiovascular (CV) health.
- Evaluate how traditional and non-traditional CV risk factors impact women’s CV risk across the life span.
- Unlock a current understanding of the presentations and mechanisms of ischemia in women.
- Examine how we can tailor cardiovascular practice to incorporate sex-specific considerations to enhance women’s CV health and well-being.
Outline
- The current state of American women’s cardiovascular (CV health)
- How traditional and non-traditional CV risk factors impact women’s CV risk throughout their lifespan
- Tailoring CV practices to incorporate sex-specific considerations
- Address care delivery inequities to enhance women’s CV health and well-being
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
10/25/2024
Irritable Bowel Syndrome in Women
Irritable bowel syndrome (IBS) affects 12% of the population, with females twice as likely to suffer from this illness. Many patients with IBS are difficult to treat, for many reasons that Dr. Peter Buch, a clinical gastroenterologist, will explore. This case-based presentation will provide the answers to challenging and common questions:
- How do you best diagnose IBS with the testing that is available today?
- Who should be referred to a gastroenterologist for care?
- Should all patients get a colonoscopy?
- What are the current evidence-based treatments?
Program Information
Objectives
- Examine the clinical usefulness of alarm signs.
- Select the appropriate workup for IBS in women.
- Choose the best prescriptive treatments for your patients.
Outline
Diagnosis of Irritable Bowel Syndrome in Women
- Clinical diagnosis, with few tests
- NOT a diagnosis of exclusion
- Meaning of “alarm signs” in differentiating IBS from other illnesses
- What tests should be considered
- Who should get a colonoscopy
- IBS occurs twice as much in women….why?
Subtypes of IBS
- Diarrhea predominant
- Constipation predominant
- Current recommendations for prescriptive treatments
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
07/29/2024
Empowering Women
Our role in providing reproductive counseling and options has been impacted with new and changing legislation. Today it is vital that providers know the options for safe and effective birth control. In the presentation you will learn the contraceptive methods in the past, why they worked or not, current options and why you would select one over another, and what is in the pipeline. Our women and families depend on getting the most accurate and up to date information from the most reliable source. Become that provider that is smarter than Google. You will be armed with information and tools to help you and your patients understand which contraceptive is a better choice and why.
Program Information
Objectives
- Examine what is birth control, and what it is doing inside the body.
- Determine contraception options from the past.
- Explain the latest contraceptives for women and men.
- Identify recommended prescribing guidelines for contraception.
- Examine the future pipeline for birth control.
Outline
Introduction/History of Contraception
- Onanism
- Dark Ages
- Timeline of Contraception Development
Latest Contraction Options
- Hormonal Birth Control
- Estrogen/ Ethinyl Estradiol (EE)
- Progesterone
- Other Hormones
- The “Pill” – Pros/Cons
- Other Birth Control Options
Prescribing Guidelines
- Which Option is Best?
- Pros/Cons
- Individualized Decision Making
Future Directions
- What’s in the Pipeline
- Clinical Trials
Target Audience
- Nurses
- Advanced Practice Nurses
- Nurse Practitioners
- Physician Assistants
- Physicians
Copyright :
06/27/2023
Solutions for Common Sleep Disturbances in Women
Join Nicole Pezzino PharmD, BCACP, CDCES for an insightful two-hour session dedicated to exploring common sleep disturbances for women. This session will delve into the complexities of sleep disorders that affect women, providing underlying causes and impact on overall health. Providers will gain a deeper understanding of pharmacological approaches used in managing sleep disturbances specific to women, including considerations for hormonal influences, medication interactions, and patient-centered treatment strategies. Through case studies and evidence-based discussions, learn practical insights and tools essential for optimizing patient care in women's sleep health.
Program Information
Objectives
- Identify key factors contributing to sleep disorders in women.
- Compare evidence-based pharmacological treatments available for managing sleep disturbances in women.
- Evaluate non-pharmacological interventions and lifestyle modifications that can complement pharmacological treatments for sleep disorders.
- Develop patient-centered strategies for counseling and educating women on sleep hygiene practices and treatment options.
Outline
Key Factors Contributing to Sleep Disorders in Women
- Hormonal influences: Impact of menstrual cycles, pregnancy, and menopause on sleep
- Psychosocial factors: Stress, anxiety, substance use disorders and posttraumatic stress disorders affecting women's sleep patterns
Pharmacological Treatments for Sleep Disorders in Women
- Pharmacological options: benzodiazepine receptor agonists (BZRAs) (including nonbenzodiazepines and benzodiazepine hypnotics), dual orexin receptor antagonists (DORAs), low-dose doxepin, ramelteon
- Off label prescription medications prescribed for insomnia and over-the counter sleep aids (i.e., diphenhydramine and doxylamine)
- Dietary supplements (i.e., melatonin, valerian, kava, magnesium) and cannabinoids
- Choosing medications based on specific sleep disorders and patient characteristics (side effect profiles, cost, clinician/patient preferences)
Non-Pharmacological Interventions & Lifestyle Modifications
- Importance of sleep hygiene practices: Establishing a consistent sleep schedule, optimizing sleep environment
- Cognitive-behavioral therapy for insomnia (CBT-I): Techniques and effectiveness
- Lifestyle modifications: Exercise, diet, and stress management techniques to improve sleep quality
Case Studies and Clinical Applications
- Presentation of case studies demonstrating the integration of pharmacological and non-pharmacological treatments
Patient-Centered Counseling and Education
- Effective communication strategies for discussing sleep disorders with women
- Providing information on sleep hygiene practices and treatment options tailored to individual needs
- Addressing patient concerns and fostering adherence to treatment plans
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
09/23/2024
Sex Hormones and their Impact on Mental Health
As the prime directive of life is the creation of new life, the ovarian and testicular produced sex hormones, estrogen, progesterone, and testosterone, are typically seen by the public and by health care professionals as solely important for sexual functioning and reproduction. But reproduction is viewed narrowly, rather than seen as involving every organ system working in optimal unity. Successful reproduction requires that the entire person is optimally healthy, including the cardiovascular, immune, gastrointestinal, musculoskeletal, genitourinary systems … as well as an optimally functioning neurological system!
Human reproduction necessitates supportive relationships, love and bonding, and critical thinking for survival to enable a substantial longevity, facilitating multiple prodigy to be conceived, born, and raised to their sexual maturity. Sex hormones should be renamed as life hormones, acknowledging their enormous contribution to the healthy functioning of every bodily system, with a keen recognition of their vital involvement in both cognitive and emotional health, which will be detailed in this presentation.
Program Information
Objectives
- Discuss the critical involvement of the sex hormones in optimal functioning of every organ system and the interrelationships among organ system to support overall bodily health and reproductive success.
- Compare the specific effects of each of the sex hormones on cognitive and emotional health.
- Explain the mechanisms involved in the support of emotional health by each of the sex hormones, including neurotransmitter production, peptides, the endocannabinoid system, and the autonomic nervous system.
- Provide an integrative approach to the optimization of sex hormone production and replacement through the decades of life.
Outline
What are the sex hormones?
- Where are they produced?
- How do they work?
- What are their primary and secondary functions-include their connections to all organ system functions
Sex hormones as neurosteroids
- What are the specific roles of sex steroids in the brain?
- What are the specific roles of sex steroids in the autonomic nervous system?
- How does the brain get sex hormones?
How do the sex steroids affect mood?
- The role of neurotransmitters
- The role of peptides
- The role of the endocannabinoid system
The integrative approach to hormone optimization
- How can the production and balance of sex hormones be optimized?
- How can sex hormones be replaced due to reduced production with aging?
- Summary of the integrative approach to hormone optimization: including nutrition, fitness, circadian rhythm alignment, relationships, toxicant avoidance, stress management
- Acknowledge the current limitations of research in this growing field
Target Audience
- Counselors
- Marriage & Family Therapists
- Nurses
- Social Workers
Copyright :
11/03/2023
Unwinding the Psychopharmacology of Anxiety Treatment in Women
Women experience anxiety disorders at a higher rate than men. In addition to this higher rate, women have unique concerns and considerations when it comes to treatment with medications. Join Dr. David Dadiomov, a board-certified psychiatric pharmacist, as he provides a comprehensive look at the complexities involved in treating anxiety disorders in women. Advance your understanding of the biological underpinnings of fear and stress responses, the neurotransmitters involved, and the role of hormones in producing these symptoms.
Gain expert insights into the unique pharmacologic targets and primary medication classes tailored for women, including SSRIs, SNRIs, gabapentinoids, and benzodiazepines. Learn practical strategies for initiating, monitoring, and adjusting anxiety medications to ensure maximum tolerability and efficacy. Special focus is given to anxiety treatment during pivotal life stages, from pre-pregnancy and pregnancy to post-partum, providing you with the knowledge to make informed decisions to understand how to optimize medication regimens. Equip yourself with the latest, evidence-based practices to deliver personalized and effective anxiety care for women.
Program Information
Objectives
- Explain the neurological basis and neurotransmitters involved in anxiety disorders in women
- Identify the pharmacologic targets used in the treatment of anxiety disorders in women
- Apply psychopharmacology concepts to current medication treatment and education of anxiety disorders in women
- Evaluate anxiety disorders, their treatment, risks, and benefits to promote optimal patient outcomes.
Outline
The Psychopharmacology of Anxiety
- How anxiety and fear manifest in the brain
- The neurotransmitters involved in anxiety disorders
- Pharmacologic targets used in the treatment of anxiety disorders in women
Anxiety Treatment Medications
- Main classes of medications used in the treatment of anxiety disorders, with an emphasis on unique attributes to women
- How to initiate medications for maximum tolerability
- Strategies to monitor and titrate medications for efficacy:
- SSRIs
- SNRIs
- Gabepentinoids
- Benzodiazepines
Pre-natal Anxiety
- Evidence based anxiety treatment in women prior to pregnancy
Anxiety in Pregnancy
- Risks and benefits of anxiety treatment on patients continuing medications into pregnancy
- Differences in the pharmacokinetics of pregnancy
Post-partum Anxiety
- Lactation considerations with medications
- Treatment of anxiety post-partum and duration of treatment
Target Audience
- Nurse Practitioners
- Nurses
- Physician Assistants
- Physicians
- Pharmacists
Copyright :
08/30/2024
Alzheimer’s Disease and Other Dementias in Women
Dementia is one of the fastest growing women’s issues in the world. In the U.S. over 13 million women are living with Alzheimer’s or caring for someone with it. Worldwide, women with dementia outnumber men two to one.
It’s a complicated puzzle and the latest research is showing us that sex impacts risk, diagnosis, and manifestation.
Dr. Sherrie All is a licensed clinical neuro-rehabilitation psychologist and brain health expert whose trainings on dementia care have helped professionals across the country to understand the disease and provide the best care possible.
In this critical session, Dr. All will bring you up to date on the latest research surrounding dementia in women PLUS give you tools and interventions you can use to prevent and reduce difficult behaviors and improve your ability to communicate with cognitively impaired patients. 
As someone in rehab who works with patients with dementia, this is one training you can’t afford to miss!
Program Information
Objectives
- Assess how the manifestations of each type of dementia impacts identification and prognosis.
- Investigate how non-verbal communication skills can help professionals identify meanings behind gestures when working with patients who have dementia.
- Determine how patient safety can be enhanced with strategies to redirect wandering and manage paranoia.
Outline
Manifestations and Prognosis for Each Type of Dementia
- The number one risk factor for dementia 
- Dementia vs. Alzheimer's - what's the difference? 
- The latest research on dementia in women
- What we know about prevention
Communication Strategies to Improve Care
- Smart communication strategies – avoid arguments and get down to business
- Three things you should never do when talking to a person with dementia
- Causes of and solutions to challenging behaviors 
- Innovative communication tools you can use when communication becomes difficult or slows to a stop
Causes of and Solutions to Challenging Behaviors
- Two ways to assess for a hidden cause of challenging behaviors
- Sundowning — How to prevent it from happening and handle it when it does
- These five signs indicate a patient might be at risk for wandering — Here's how to spot them
- Hallucinations vs. delusions vs. schizophrenia — How do you tell the difference?
- Paranoia management strategies
Target Audience
- Athletic Trainers
- Chiropractors
- Exercise Physiologists
- Occupational Therapists
- Occupational Therapy Assistants
- Personal Trainers
- Physical Therapists
- Physical Therapy Assistants
- Physicians
- Physician Assistants
- Strength and Conditioning Coaches
Copyright :
05/20/2021
Tackling Autoimmunity with Targeted Nutrition and Lifestyle Tactics
Autoimmunity is on the rise. It’s the third most common cause of chronic illness in the US and women lead the pack as 80% of those affected. Sadly, it takes an average of 4.5 years to get diagnosed. We owe it to ourselves and our patients to better understand how to manage the condition holistically.
Dive into environmental and physiological risk factors, when and how to properly test and powerful nutrition and lifestyle tactics that manage autoimmune dysfunction at the cellular level.
Program Information
Objectives
- Evaluate the definition and prevalence of, as well as diagnostic measurements (subjective and objective) for common autoimmune conditions.
- Assess the 3 primary causes of autoimmunity: genetics, gut dysfunction, and environmental triggers.
- Determine a customized and systemized approach to optimizing the management of autoimmunity via personalized nutrition, supplementation, gut repair, activity, sleep, mindfulness, and avoidance of environmental toxins.
Outline
Autoimmunity is On the Rise
- Definition and prevalence
- Different forms
- Identification
- Common symptoms – subjective assessment
- Lab values – objective assessment
- Causes
- Genetic predisposition
- Intestinal hyperpermeability
- Environmental trigger
Holistic management of Autoimmunity
- Diet/nutrition
- Supplementation
- Gut repair
- Activity/exercise
- Sleep optimization
- Stress management
- Reduction/omission of environmental toxins
Target Audience
- Athletic Trainers
- Chiropractors
- Nurses
- Occupational Therapists
- Occupational Therapy Assistants
- Physical Therapists
- Physical Therapy Assistants
Copyright :
03/20/2024
Body Image and Eating Disorders in Women
Eating disorder symptoms and body image preoccupation have been identified in increasing numbers of women. In practice, you may see women who are seeking treatment for chronic, recurrent, or late onset eating disorders. But many health care providers do not fully understand how to screen for and manage these conditions. Featherston will describe the contributing factors that relate to the unique experience of eating disorders. You will le
Program Information
Objectives
- Define eating disorder components and behaviors as they relate to women.
- Explain the role of emotional dysregulation in eating disorders.
- Review psychiatric comorbidities of eating disorders.
- Explain the etiologies of various medical sequence of eating disorders.
- Synthesize the relationship between trauma (especially ACE scores) on eating disorders.
- Explain the etiology of obstetrical and gynecological impact of eating disorders.
- Describe variation in marginalized groups in regard to eating disorder presentations.
Outline
Introduction/Body Image Definition and Development
- Sociocultural Factors
- Problematic Tools: Body Mass Index
Obesity, Conceptualized
- Weight Bias and Obesity Stigma in Healthcare
Eating Disorders
- Defining Eating Disorders
- Connecting Body Image and Eating Disorders
- Trauma and Numbness: Function of an Eating Disorder
- Definitions and Prevalence: Scope of the Problem
- Eating Disorders and the Ego
Special Categories of Women
- Adolescents
- Female Athletes and Performers
- Adolescents in Pregnancy with ED’s
- Pregnant Adult Women
- Postpartum Dyads
- Lactating Women
- Elderly Women
- Scars and Surgery from Chronic Illness
- Racial and Ethnic Influences
- (Cisgender) Queer Women
- Transgender Women
Assessment
- Transdiagnostic Components of Eating Disorders
- Screening for Eating Disorders: SCOFF
- General Medical Implications
- Physical Assessment Clues: Anorexia
- Physical Assessment Clues: Bulimia
- Laboratory Clues
- Common Psychiatric Comorbidities
Intuitive Eating
Morbidity and Mortality of Eating Disorders
COVID-19 Pandemic
Obstetric and Gynecological Complications of Eating Disorders
Anorexia Nervosa
Bulimia Nervosa
Binge Eating Disorder
OSFED and EDNOS
Sexual Functioning
Treatment
Principles of Evidence-Based Treatment
Psychological Treatment and Levels of Care
- Nutritional/ Dietetic Treatment
- Supportive Medical Treatment
Ethics in ED Treatment
- Environment and Patient Visit Consideration
- Ethical Considerations of Anorexia
Case Studies/Conclusion/Summary
Resources/Book Recommendations/Professional Organizations and Continuing Education Resources
Target Audience
- Nurses
- Nurse Practitioners
- Physician Assistants
- Physicians
- Counselors
- Psychiatrists
- Psychologists
Copyright :
06/28/2023